Mediterranean diet, micronutrients and prostate carcinoma: A rationale approach to primary prevention of prostate cancer

Archivio Italiano di Urologia e Andrologia

Volumn 75, Issue 3, 2003, Pages 166-178

  Miano, Lucio ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b NONE   (Italy)

Author keywords

Mediterranean diet; Prevention; Prostatic carcinoma

Indexed keywords

ALPHA TOCOPHEROL; ANGIOGENESIS INHIBITOR; ANTIOXIDANT; AROMATASE INHIBITOR; COLECALCIFEROL; DNA TOPOISOMERASE INHIBITOR; HYDROXYSTEROID DEHYDROGENASE; ISOFLAVONOID; LYCOPENE; PHYTOESTROGEN; POLYPHENOL; POLYUNSATURATED FATTY ACID; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SELENIUM; STEROID 5ALPHA REDUCTASE INHIBITOR; TYROSINE 3 MONOOXYGENASE; ZINC; TRACE ELEMENT;

CANCER PREVENTION; CARCINOGENESIS; CEREAL; CONFERENCE PAPER; DAIRY PRODUCT; DIET; DIETARY FIBER; EATING HABIT; FAT INTAKE; FISH; FRUIT; HUMAN; ITALY; MEAT; NUTRIENT; OBESITY; PROSTATE CARCINOMA; SOYBEAN; TEA; VEGETABLE; MALE; MEDITERRANEAN DIET; PROSTATE TUMOR; REVIEW;

DIET, MEDITERRANEAN; HUMANS; MALE; MICRONUTRIENTS; PROSTATIC NEOPLASMS;

EID: 0242389586     PISSN: 11243562     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (84)

1. Bono AV, Rocca Rossetti S, Vercelli M, Berrino F, Verdecchia A. Ricerca epidemiologica italiano sul carcinoma prostatico (REICAP). Segrate: Depha Team, 1997
2. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. C.A. Cancer J Clin 1996; 46:5
3. Kellof GJ, Lieberman R, Steele VE, Boone CW, Lubet RA, Kopelovitch L, Malone WA, Crowell JA, Sigman CC. Chemoprevention of prostate cancer: Concepts and strategies. Eur Urol 1999; 35:342
4. Kellof FJ, Crowell JA, Steel VE, Laber RA, Boone CW, Malone WA, Hawk ET, Liebermann R, Lawrence JA, Kopelovich L, Ali I, Viner JL, Sigman C. Progress in cancer chemoprevention. Ann NY Acad Sci 1999; 889:1
5. Fair WR, Fleshner NE, Heston W, Fleshner NE, Heston W. Cancer of the prostate: A nutritional disease? Urology 1997; 50:840
6. Blumenfeld AJ, Fleshner N, Casselman B, Trachtenberg J. Nutri-tional aspects of prostate cancer: A review. Can J Urol 2000; 7:927
7. Schröder FH, Kranse R, Dijk MA, Blom JM, Tijburg LM, Weststrate JA, Dagnelie PC. Tertiary prevention of prostatic cancer by dietary intervention: Results of a randomized, double-blind, placebo-controlled cross-over study. Eur Urol 2000; 37:24
8. Hanash KA, Al-Othaimeen A, Kattan S, Lindstedt E, Al-Zahrani H, Merdad T, Peracha A, Kardar AH, Aslam M, Al-Akkad A. Prostatic carcinoma: A nutritional disease? Conflicting data from the Kingdom of Saudi Arabia. J Urol 2000; 164:1570
9. Grant WB. An ecologic study of dietary links to prostate cancer Altern Med Rev 19991; 4:162
10. Thompson IM, Coltman CA Jr, Crowley J. Chemoprevention of prostate cancer: The prostate Cancer Prevention Trial. Prostate 1997; 33:217
11. Nabhan C, Bergan R. Chemoprevention in prostate cancer: Cancer Treat Res 2001; 106:103
12. Yip I, Heber D, Aronson W. Nutrition and prostate cancer. Urol Clin North Am 1999; 26:403
13. Schmitz-Drager BJ, Eichholzer M, Beiche B, Ebert T. Nutrition and prostate cancer. Urol Int 2001; 67:1
14. Kamat AM, Lamm DL. Chemoprevention of Urological cancer. J. Urol 1999; 161:1748
15. Sala G, Bono AV. Dieta e cancro della prostata. Varese: Josca Ediz., 2001
16. Schulman CC, Kelloff GJ. Strategies for the chemoprevention of prostate cancer. Eur Urol 1999; 35:340
17. Muir CS, Nectoux J, Staszewski J. The epidemiology of prostatic cancer: Geographical distribution and timetrends. Acta Oncol 1991; 30:133
18. Haenszel W., Kurihara M. Mortality from cancer and other diseases among Japanese in the United States J. Natl Cancer Inst 1968; 40:43
19. Shimizu H, Ross, RK, Benstein L, Yatani R, Henderson BE, Mach TM. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer 1991; 63:936
20. Wynder EL, Mabuchi K, Whitmore WF Jr. Epidemiology of cancer of the prostate. Cancer 1971; 28:344
21. Sahr WA, Haas G., Cassin BJ, et al. The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol 1993; 150:379
22. Rose DP, Boyer AP, Wynder EL. International comparison of mortality rates for cancer of the breast, ovary, prostate, and colon per capita food consumption. Cancer 1986; 58:2363
23. West DW, Slattery ML, Robinson LM, French RK, Mahoney AW. Adult dietary intake and prostate cancer risk in Utah: a case-control study with special emphasis on aggressive tumors. Cancer causes Control 1991; 2:85
24. Giovannucci EJ, Rimm, EB, Colditz GA, Stampfer, MJ. Asherio, A, Chute CC, Willett WC. A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst 1993; 85:1571
25. Lew EA, Garfinkel L. Variations in mortality by weight among 750,000 men and women. J Chron Dis 1979; 32:563
26. Rose DP, Connolly JM. Dietary fat, fatty acids and prostate cancer. Lipids 1992; 27:798
27. Godley PA, Campbell MK, Gallagher P, Martinson FE, Mohler, JL, Sandler RS. Biomarkers of essential fatty acid consumption and risk of prostatic carcinoma. Cancer Epidemiol Biomark Prev 1996; 5:889
28. Ewings P, Bowie C. A case-control study of cancer of the prostate in Somerset and Cast Devon. Br J Cancer 1996; 74:661
29. Rose DP. Dietary fatty acids and prevention of hormone-responsive cancer. Proc Soc Exp Biol Med 1997; 216:224
30. Wang Y, Heston W, Corr J, et al. Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. J Natl Cancer Inst 1995; 87:1427
31. Hill P, Winder EL, Garbaczewski L, et al. Diet and urinary steroids in black and white North American men and black South African men. Cancer Res 1987; 47:2982
32. Dorgan JF, Judd JT, Longrope C, Brown C, Scatzkin A, et al. Effects of dietary fat and fiber onplasma and urine estrogens in men A controlled feeding: study. Am J Cin Nutr 1996; 64:850
33. Howie BJ, Shultz TD. Dietary and hormonal interrelationships among vegetarian Seventh-Day Adventist and non vegetarian men. Am J Clin Nutr 1985; 42:127
34. Fleshner NE, Kucuk O. Antioxidant dietary supplements: rationale and current status ad chemopreventative agents for prostate cancer. Urology (Suppl) 2001; 57:90
35. Ripple MO, Henry WF, Rago RP, et al. Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma lines. J Natl Cancer Inst 1997; 89:40
36. Rao AV, Fleshner N, Agarwal S. Serum and tissue lycopene and biomarkers of oxidation in prostate cancer patients. A case-control study. Nutr Cancer 1999; 33:159
37. Lee WiH, Isaacs WB, Bova GS, et al. CG island methylation changes near the GSTP1 gene in prostatic carcinoma cells detected using the polymerase chain reaction, a new prostate cancer biomarker. Cancer Epidemiol Biomarkers Prev 1997; 44:3
38. Das S. Vitamin E in the genesis and prevention of cancer. Acta Oncol 1994; 33:615
39. Fleshner N, Fair W, Huryk R, Heston WDW. Vitamin E inhibits the high-fat diet-promoted growth of established human LnCaP tumors in nude mice. J Urol 1990; 161:1651
40. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group: the effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330:1029
41. Nomura AM, Stemmermann GN, Lee J, Craft NE. Serum micronutrients and prostate cancer in Japanese Americans in Hawaii. Cancer Epidemiol Biomarkers Prev 1997; 6:487
42. Helzlsouer KJ, Huang HY, Alberg AJ, Hoffman S, Burke A, Norhus EP, et al. Association between alphatocopherol, gamma-tocopherol, selenium and subsequent prostate cancer. J Natl Cance Inst 2000; 92:2018
43. Klein EA, Thompson IM, Lippman SM, Goodman PJ, Albanes D, Taylor PR, et al. SELECT: the next prostate cancer prevention trial. J Urol 2001; 166:1311
44. Combs GF Jr, Clark LC, Turnbull BW. Reduction of cancer risk with an oral supplement of selenium. Biomed Environ Sci 1997; 10:227
45. Yoshizawa K, Willet WC, Morris SJ, Stampfer KJ, Spiegelman D, Rimm EB, Giovannucci E. Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst 1998; 90:1219
46. Clark LC, Dalkin B, Krongrad A, Combs FG Jr, Turnbull BW, Slate EH, Witherington R, Herlong JH, Janosko E, Carpenter D, Borosso C, Falk S, Rounder J. Decreased incidence of prostate cancer with selenium supplementation: Results of a double-blind cancer prevention trial. Br J Urol 1998; 81:730
47. Clark LC, Combs GF, Turnbull BW, Slater EH, Chalker DK, Chow J, Davis LS, Glover PA, Graham, FG, Gross EG, Krongrac A, Lesher JL Jr, Park HK, Sanders BB Jr., Smith CL, Taylor JR. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomised controlled trial. JAMA 1997; 276:1957
48. Schwartz GG, Hill CC, Oeler TA, Becich MJ, Bahnson RR. 1,25 - Dihydroxy- 16-ene 23-yne-vitamin D3 and prostate cancer cell proliferation in vivo. Urology 1995; 46:365
49. Peehl DM, Showronski RJ, Leung GK, Wong ST, Stamey TA, Feldman D. Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells. Cancer Res 1994; 54:805
50. Schwartz GG, Wang MH, Zang M, Singh RK, Siegal GP. 1-Alpha, 25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells. Cancer Epidemiol Biomark Prev 1997; 6:727
51. Skowronski RJ, Peehl DM, Feldman D. Vitamin D and prostate cancer: 1,25-dihydrovitamin D3 receptors and actions in human prostate cancer cell lines. Endocrinology 1993; 132:1952
52. Schwartz GG, Hulka BS. Is vitamin D deficiency a risk factor for prostate cancer? (hypothesis) Anticancer Res 1990; 10:1307
53. Sung V, Feldman D. 1,25-Dihydroxyvitamin D3 decreases human prostate cancer cell adhesion and migration. Mol Cell Endocrinol 2000; 164:133
54. Cross C, Stamey T, Hancock S, Feldman D. Treatment of early recurrent prostate cancer with 1,25-dihydroxyvitamin D3. J Urol 1998; 159:2035
55. Konety BR, Johnson CS, Trump DL, Getzenburg RH. Vitamin D in the prevention and treatment of prostate cancer. Semin Urol Oncol 1999; 17:77
56. Zaho XY, Peehl DM, Navone NM, Feldman D. 1α, 25-Dihydroxyvitamin D3 inhibits prostate cancer cell growth by androgen-dependent and androgen-indipendent mechanisms. Endocrinology 2000; 141:2548
57. Shi J, Le Maguer M. Lycopene in tomatoes: chemical and physical properties affected by food processing. Crit Rev Food Sci Nutr 2000; 40:1
58. Giovannucci E. Tomatoes, tomato-based products, lycopene, and cancer: Review of the epidemiologic literature. J Natl Cancer Inst 1999; 91: 317
59. Agarwal S, Rao AV. Tomato lycopene and its role in human health and chronic diseases. Can Med Assoc J 2000; 163:739
60. Pastori M. Lycopene in association with alpha-tocopherol inhibits physiological concentrations proliferations prostate carcinoma cells. Chem Biophys Res Comun 1998; 250:582
61. Gann PH, Ma J, Giovannucci E, Willet W, Sacks FM, Hennekens CH, Stamper MJ. Lower prostate cancer risk in men with elevated plasma lycopene levels: Results of a prospective analysis. Cancer Res 1999; 59:1225
62. Mills PK, Beeson WL, Phillips PL, Fraser GE. Cohort study of diet, lifestyle, and prostate cancer in Adventist men. Cancer 1989; 64:598
63. Hsing, AW. Diet, tobacco use, and fatal prostate cancer: results from the Lutheran Brotherhood cohort study. Cancer Res 1990; 50:6831
64. Giovannucci E, Ascherio A, Rimm E, et al. Intake of carotenoids and retinol. in relationship to risk of prostate cancer. J Natl Cancer Inst 1995; 87:1767
65. Kucuk O, Sarkar FH, Sakr W, Djuric Z, Pollak MN, Hhachik F, et al. Phase II randomised clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidermiol Biomarkers Prev 2001; 10:861
66. Conney AH., Wand ZY, Huang MT, Lou YR, Yang CS. Inhibitory effects of green and black tea on carcinogenesis. Proc Am Assn Cancer Res 1995; 36:704
67. Carlin BI, Pretlow TG, Pretlow TP, Resnick MI. Green tea polyphenols inhibit growth of prostate cancer xenograft CWR22: implications for prostate cancer chemoprevention. Proc Am Assn Cancer Res 1996; 37:A1915
68. Gupta S, Ahmad N, Mohan RR, Husain MM, Mukhtar H. Prostate cancer chemoprevention by green tea: in vitro and in vivo inhibition of testosterone-mediated induction of ornithine decarboxylase Cancer Res 1999; 59:2115
69. Paschka AG, Butler R, Young CY. Induction of apoptosis in prostate cancer cell lines by the green tea component, epigallo-catechin-3-gallate. Cancer Lett (Ireland) 1998; 130:1
70. Messina MJ, Persky V, Setchell KD, Barnes S. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer 1994; 21:113
71. Jacobsen BK, Knutsen SF, Fraser GE. Does high soy milk intake reduce prostate cancer incidence? The Adventist Health Study. Cancer Causes Control 1998; 9:553
72. Aronson WJ, Tymchuk CN, Elashoff RM, Mc Bride WH, McLean C, Wang H, Heber D. Decreased growth of human prostate LNCaP tumors in SCID mice fed a low-fat, soy protein diet with isoflavones. Nutr Cancer 1999; 35:130
73. Kolonel LN, Hankin JH, Whittemore AS, Wu AH, Gallagher RP, Wikens LR, John EM, Howe GR, Dreon DM, West DW, Paffenbarger RS Jr. Vegetables, fruits, legumes and prostate cancer: A multiethnic case-control study. Cancer Epidemiol Biomarkers Prev 2000; 9:795
74. Adlercreutz H, Markkanen H, Watanabe S. Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 1993; 342:2209
75. Strom SS, Yamamura Y, Duphorne CM, Spitz MR, Babaian RJ, Pillow PC, Hursting SD. Phytoestrogen intake and prostate cancer: A case-control study using a new database. Nutr Cancer 1999; 33:20
76. Brandi ML. Aggiornamento Medico 1999; 23:173. Citato da Sala G, Bono AV
77. Evans BAJ, Giffiths K, Morton M. Inhibition of 5-alfa-reductase and 17-beta-hydrossysteroid dehydrogenase in genital skin fibroblasts by dietary lignans and isoflavonoids. J Endrocinol 1995; 147:295
78. Fotsis T, Pepper M, Aldercruetz H, Fleischmann G, Hases T, Montesano R, Schweigerer L. Genistein a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci 1993; 90:2690
79. Griffiths K, Denis L, Turkes A, Morton MS. Possible relationship between dietary factors and pathogenesis of prostate cancer. Int J Urol 1998; 5:195
80. Geller J, Sionit L, Partido C, Li L, Tan X, Youngkin T, Nachtsheim D, Hoffman RM. Genistein inhibits the growth of human-patient BPH and prostate cancer in histoculture. Prostate 1998; 34:75
81. Zaichick VY, Sviridova TV, Zaichick SV. Zinc concentration in human prostatic fluid: normal, chronic prostatitis, adenoma and cancer Int Urol Nephrol (Hungary) 1996; 28:687
82. Wong YC, Wang YZ, Lee JS, Tam NN, Lee D. Changes in serum and tissue zinc levels in sex hormone-induced prostatic carcinogenesis in the noble rat. Tumour Biol 2000; 21:328
83. Costello LC, Liu Y, Zou J, Franklin RB. Evidence for a zinc uptake transporter in human prostate cancer cells which is regulared by prolactin and testosterone. J Biol Chem 1999; 274:17499
84. Liang JY, Liu YY, Zou J, Franklin RB, Costello LC, Feng P. Inhibitory effect of zinc on human prostatic carcinoma cell growth. Prostate 1999; 40:200